News On Japan

Japan study shows women more likely to get skin rash from Moderna shot

Jun 02 (Japan Today) - A study in Japan found that women were significantly more likely than men to develop rash-like side effects after a first dose of Moderna Inc's COVID-19 vaccine.

The study of 5,893 participants between May and November last year showed that 22.4% of women developed delayed skin reactions after the first shot, compared to 5.1% of men.

The symptoms were mild and not considered a contraindication of the mRNA-based vaccine, according to the June 1 report in the Journal of the American Medical Association.

Delayed skin reactions, happening on or after six days from the shot, have been also reported as a rare adverse event in the United States and Europe, according to the authors from Tokyo's Self-Defense Forces Central Hospital.

But the incidences appear to be higher in Japan, they wrote, perhaps because of a higher awareness of such symptoms in the country.

News On Japan
POPULAR NEWS

Rain affected parts of Japan on Tuesday morning as a low-pressure system and front moved through, bringing heavier downpours in some areas. Skies are expected to clear across much of the country this afternoon. However, yellow sand drifting in from the Asian continent is forecast to spread over a wide area, raising concerns over reduced visibility and worsening health conditions.

Japan's weather agency and the Cabinet Office issued a 'Hokkaido-Sanriku Offshore Subsequent Earthquake Advisory' after an earthquake measuring upper 5 on Japan's seismic intensity scale struck off Sanriku.

JR East has launched a preview version of its new online Shinkansen booking platform, JRE GO, promising reservations in as little as one minute and easier handling of sudden schedule changes.

A bear that had remained in a residential area in central Sendai since early Sunday morning was euthanized last night in an emergency cull. No injuries were reported.

Police investigating the death of an 11-year-old boy whose body was found in a forest in Kyoto Prefecture believe his father moved the remains between several locations over a number of days in an apparent attempt to conceal the crime.

MEDIA CHANNELS
         

MORE Sci-Tech NEWS

Japan's logistics sector is struggling with a severe driver shortage, driving efforts to develop autonomous trucks as a potential solution to a growing freight transport crisis.

The fleet of 190 EV buses introduced for the Osaka-Kansai Expo has been withdrawn from plans for reuse on regular routes, with Osaka Metro abandoning efforts to redeploy the vehicles after the event.

Chinese smartphone maker OPPO announced it will release its foldable smartphone “OPPO Find N6” in Japan on April 15th, marking the company’s first entry into the country’s foldable device segment.

An event aimed at bringing the mysteries of the deep sea closer to the public was held in Nago City, where a researcher who has explored oceans around the world delivered a talk.

The Japan Maritime Self-Defense Force will withdraw from Antarctic research vessel operations after nearly six decades, with private-sector entities expected to take over following the retirement of the icebreaker Shirase in fiscal 2034.

As temperatures rise, concerns about body odor return, drawing attention to a lesser-known scientific field that examines the invisible gases emitted from human skin, with Tokai University professor Yoshika Sekine leading research that could even help detect disease and stress levels.

Five years have passed since Japan’s flagship supercomputer Fugaku, based in Kobe, began full-scale operations, achieving a series of breakthroughs by simulating complex phenomena on a massive and highly precise scale, ranging from the formation of galaxies to the behavior of nerve cells.

Rising tensions in the Middle East are raising concerns over potential disruptions to medical supplies in Japan, particularly due to uncertainty surrounding naphtha used in products such as gloves and gowns, with hospitals warning that a halt in supply could significantly impact medical care while authorities move to reassure that stockpiles are sufficient for the time being.